Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Teijin Pharma presents novel CaSR antagonists with promising in vivo activity

Oct. 16, 2012

NKTR-171 demonstrates efficacy in animal models of neuropathic pain

Oct. 16, 2012

GNbAC-1, a novel humanized antibody for the treatment of MS

Oct. 15, 2012

Inwardly rectifying potassium channel, a novel immune target in MS

Oct. 15, 2012

Forkhead box M1 expression predictive of survival in patients with renal cell carcinoma

Oct. 15, 2012

Plasma thymosin alpha-1 levels may distinguish renal cell carcinoma from urothelial carcinoma

Oct. 15, 2012

Metformin shows promise in treating prostate cancer

Oct. 15, 2012

Researchers find possible biomarker for renal cell carcinoma

Oct. 11, 2012

Significant reduction of HbA1c seen with VRS-859 in clinical trial

Oct. 11, 2012

In vitro, in vivo and phase I data on DS-8587 presented

Oct. 11, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...